MetaVia Inc. (MTVA) Financial Ratios
11 years of historical data (2014–2024) · Healthcare · Biotechnology
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
0.12
↓-34% vs avg
5yr avg: 0.18
30Y Low0.2·High0.2
ROE
↑
-224.2%
↑-38% vs avg
5yr avg: -162.1%
30Y Low-354%·High-65%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
MTVA Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
MetaVia Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $7M | $1M | — | — | — | — | — | — | — | — | — |
| Enterprise Value | $-9110055 | $-14449458 | — | — | — | — | — | — | — | — | — |
| P/E Ratio → | -0.03 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | — | — | — | — | — | — | — | — | — | — | — |
| P/B Ratio | 0.12 | 0.18 | — | — | — | — | — | — | — | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
MTVA EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
MTVA Profitability
Margins and return-on-capital ratios measuring operating efficiency
A negative ROE of -224.2% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — | — | — | — | — | — |
| Operating Margin | — | — | — | — | — | — | — | — | — | — | — |
| Net Profit Margin | — | — | — | — | — | — | — | — | — | — | — |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -224.2% | -224.2% | -64.9% | -76.9% | -140.2% | -304.5% | -173.4% | — | -272.0% | -353.5% | — |
| ROA | -141.3% | -141.3% | -44.3% | -55.5% | -110.1% | -233.4% | -233.1% | -136.0% | -152.7% | -99.8% | -373.3% |
| ROIC | — | — | — | — | — | — | — | — | — | — | — |
| ROCE | -232.2% | -232.2% | -82.4% | -107.9% | -139.6% | -302.3% | -252.4% | -190.9% | -199.2% | -181.4% | — |
MTVA Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $16M exceeds total debt of $136000, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.02 | 0.02 | 0.01 | — | 0.00 | 0.01 | 0.01 | — | 2.55 | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -2.00 | -1.33 | -1.53 | -1.12 | -1.39 | -1.12 | — | -2.14 | -1.16 | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | — | -8.96 | — | — | -917.09 | -387.15 | -115.82 | — | -10.60 |
Net cash position: cash ($16M) exceeds total debt ($136000)
MTVA Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.94x means MetaVia Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 2.85x to 1.94x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.94 | 1.94 | 3.78 | 2.85 | 7.69 | 2.89 | 6.78 | 17.39 | 2.97 | 6.00 | 0.41 |
| Quick Ratio | 1.94 | 1.94 | 3.78 | 2.85 | 7.69 | 2.89 | 6.78 | 17.39 | 2.97 | 6.00 | 0.41 |
| Cash Ratio | 1.94 | 1.94 | 3.76 | 2.83 | 7.60 | 2.73 | 6.68 | 12.99 | 2.89 | 5.83 | 0.41 |
| Asset Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
MTVA Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
MetaVia Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | — | — | — | — | — | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | — | — | — | — | — | — | — | — | — |
| Shares Outstanding | — | $705193 | $461009 | $29246 | $8767 | $6143 | $1979 | $209 | $157 | $140 | $139 |
Peer Comparison
Compare MTVA with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 MTVAYou | $7M | -0.0 | — | — | — | — | -224.2% | — | — |
 MVIS | $189M | -1.8 | — | — | -1435.4% | -5743.8% | -182.1% | -98.3% | — |
 VUZI | $232M | -6.8 | — | — | — | -517.6% | -261.1% | -1070.8% | — |
 KOPN | $755M | -14.6 | — | — | 20.6% | -85.6% | -166.2% | -172.3% | — |
 IMMR | $211M | 1.6 | 3.0 | — | 29.1% | 10.7% | 24.1% | 21.2% | 2.1 |
 META | $1.6T | 26.3 | 15.8 | 33.9 | 82.0% | 41.4% | 30.2% | 27.6% | 0.8 |
 RBLX | $32B | -29.1 | — | 23.7 | 78.1% | -25.2% | -365.0% | -87.7% | — |
 U | $12B | -27.8 | 312.5 | 28.9 | 74.2% | -22.8% | -11.6% | -7.8% | 62.2 |
 NVDA | $5.1T | 43.2 | 38.6 | 53.2 | 71.1% | 60.4% | 101.5% | 81.8% | 0.1 |
 QCOM | $214B | 40.4 | 15.9 | 16.7 | 55.4% | 27.9% | 23.3% | 29.1% | 1.2 |
 MSFT | $3.1T | 30.9 | 19.7 | 43.7 | 68.8% | 45.6% | 33.3% | 24.9% | 0.7 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 11 years · Updated daily
See MTVA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MTVA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MTVA vs MVIS
Side-by-side business, growth, and profitability comparison vs MicroVision, Inc..
Start ComparisonMTVA — Frequently Asked Questions
Quick answers to the most common questions about buying MTVA stock.
What is MetaVia Inc.'s P/E ratio?
MetaVia Inc.'s current P/E ratio is -0.0x. This places it at the 50th percentile of its historical range.
What is MetaVia Inc.'s ROE?
MetaVia Inc.'s return on equity (ROE) is -224.2%. The historical average is -201.2%.
Is MTVA stock overvalued?
Based on historical data, MetaVia Inc. is trading at a P/E of -0.0x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.